Earnings Outlook For ARS Pharmaceuticals

ARS Pharmaceuticals (NASDAQ:SPRY) will release its quarterly earnings report on Wednesday, 2025-08-13. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate ARS Pharmaceuticals to report an earnings per share (EPS) of $-0.47.

The market awaits ARS Pharmaceuticals's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

It's important for new investors ...